Franklin Resources
DAWN

Franklin Resources’s Day One Biopharmaceuticals DAWN Stock Holding History

Franklin Resources’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.13M Sell
52,623
-103
-0.2% -$1.45K ﹤0.01% 2136
2025
Q4 		$491K Sell
52,726
-3,424,300
-98% -$28.6M ﹤0.01% 2413
2025
Q3 		$24.5M Sell
3,477,026
-620,599
-15% -$4.27M 0.01% 885
2025
Q2 		$26.6M Buy
4,097,625
+79,255
+2% +$545K 0.01% 839
2025
Q1 		$31.9M Buy
4,018,370
+135,418
+3% +$1.46M 0.01% 753
2024
Q4 		$49.2M Buy
3,882,952
+13,320
+0.3% +$185K 0.01% 622
2024
Q3 		$55.3M Buy
3,869,632
+87,262
+2% +$1.25M 0.02% 564
2024
Q2 		$52.1M Sell
3,782,370
-24,420
-0.6% -$357K 0.02% 543
2024
Q1 		$62.9M Sell
3,806,790
-430,005
-10% -$6.44M 0.02% 502
2023
Q4 		$61.9M Buy
4,236,795
+169,463
+4% +$2.05M 0.03% 443
2023
Q3 		$49.9M Buy
4,067,332
+1,664
+0% +$21.7K 0.03% 494
2023
Q2 		$48.5M Buy
4,065,668
+658,797
+19% +$8.6M 0.02% 529
2023
Q1 		$45.5M Buy
3,406,871
+934,022
+38% +$18.2M 0.02% 547
2022
Q4 		$53.2M Sell
2,472,849
-3,857
-0.2% -$79.1K 0.03% 511
2022
Q3 		$49.6M Buy
2,476,706
+11,326
+0.5% +$241K 0.03% 525
2022
Q2 		$44.1M Buy
2,465,380
+922,521
+60% +$9.53M 0.02% 578
2022
Q1 		$15.3M Buy
1,542,859
+581,633
+61% +$7.68M 0.01% 918
2021
Q4 		$16.2M Buy
961,226
+370,699
+63% +$7.62M 0.01% 945
2021
Q3 		$14M Buy
590,527
+71,561
+14% +$1.71M 0.01% 976
2021
Q2 		$11.8M Buy
+518,966
New +$10.8M ﹤0.01% 984

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Franklin Resources's DAWN Position: Q1 2026 in Review

Franklin Resources reduced its Day One Biopharmaceuticals (DAWN) stake by 0.2% in Q1 2026, selling an estimated $1.45K and leaving 52,623 shares worth $1.13M. The position accounts for ﹤0.01% of the portfolio, ranked #2136.

Franklin Resources first reported a position in DAWN in Q2 2021 and has held it in 20 quarters since. The position peaked at $62.9M in Q1 2024. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • Franklin Resources held 52,623 shares of Day One Biopharmaceuticals worth $1.13M as of Q1 2026.
  • Franklin Resources sold 103 Day One Biopharmaceuticals shares in Q1 2026, an estimated $1.45K.
  • Day One Biopharmaceuticals made up ﹤0.01% of Franklin Resources's portfolio in Q1 2026, its #2136 holding.
  • Franklin Resources first reported a position in Day One Biopharmaceuticals in Q2 2021 and has held it in 20 quarters since.
  • Franklin Resources's Day One Biopharmaceuticals position peaked at $62.9M in Q1 2024.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on Franklin Resources's 13F filing for Q1 2026, filed 13 May 2026.